566 studies found for:    Open Studies | "Infant, Newborn, Diseases"
Show Display Options
Rank Status Study
1 Unknown  Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
Conditions: Glomerulonephritis, Membranous;   Neonatal Diseases and Abnormalities;   Hemochromatosis
2 Recruiting Evaluation of Conditional Cash Transfers to Increase Retention in PMTCT Services in Akwa Ibom State, Nigeria
Conditions: HIV;   HIV Infections;   Pregnancy;   Infant, Newborn, Diseases
Intervention: Behavioral: Conditional Cash Transfers
3 Not yet recruiting Effect of Vitamin D Replacement on Maternal and Neonatal Outcomes
Conditions: Hypovitaminosis D;   Pregnancy Complications;   Infant, Newborn, Diseases
Intervention: Dietary Supplement: Euro D
4 Recruiting Early-Onset Sepsis an NICHD/CDC Surveillance Study
Conditions: Infant, Newborn, Diseases;   Early Onset Neonatal Sepsis;   Early-Onset Meningitis
5 Recruiting Transfusion of Prematures Trial
Conditions: Infant, Newborn, Diseases;   Infant, Extremely Low Birth Weight;   Infant, Small for Gestational Age;   Bronchopulmonary Dysplasia (BPD);   Anemia
Interventions: Procedure: Liberal Cell Transfusion;   Procedure: Restricted red cell transfusion
6 Unknown  Reduced Infant Response to a Routine Care Procedure After Glucose 25% Analgesia in Comparison to Materna RTF Stage 1
Condition: Infant, Newborn, Diseases
Interventions: Drug: Glucose 25%;   Dietary Supplement: Materna RTF Stage 1;   Other: Water for Injection
7 Recruiting Randomized Controlled Trial Comparing a Conservative Management and Laser Surgery
Conditions: Blood and Blood Disorders;   Anemia, Neonatal;   Hematologic Disease;   Infant, Newborn, Diseases
Intervention: Procedure: Fetoscopic laser surgery
8 Unknown  Diazoxide In the Management Of Hypoglycemic Neonates
Conditions: Infant, Newborn, Diseases;   Pregnancy in Diabetics;   Infant, Diabetic Mother;   Hypoglycemia;   Infant, Large for Gestational Age
Interventions: Drug: Diazoxide;   Drug: Ora-plus
9 Unknown  Prevention of Perinatal Sepsis (PoPS): Evaluation of Chlorhexidine Wipes of Birth Canal and Newborn
Conditions: Infant, Newborn, Diseases;   Sepsis;   Puerperal Infection
Interventions: Drug: Chlorhexidine;   Procedure: Birth canal wipe;   Procedure: sterile water external genital wipe
10 Unknown  Functional Magnetic Resonance Imaging in Infants
Conditions: Healthy;   Infant, Newborn, Diseases
11 Unknown  Study of Energy Requirements in Critically Ill Newborns
Condition: Respiratory Distress Syndrome
12 Unknown  Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis
Conditions: Sepsis;   Respiratory Distress Syndrome;   Respiratory Distress Syndrome, Adult
Intervention: Drug: vasoactive intestinal peptide
13 Not yet recruiting Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels
Condition: Neonatal Diabetes Secondary to Mutation in the Potassium Channel
Intervention: Drug: Glibenclamide
14 Recruiting Physiological Disturbances Associated With Neonatal Intraventricular Hemorrhage
Conditions: Intraventricular Hemorrhage;   Autoregulation
Interventions: Other: Hypercapnia;   Other: Normocapnia
15 Not yet recruiting High Flow Ventilation With Volume Guarantee
Conditions: Rds;   Pulmonary Hypertension;   Meconium Aspiration Syndrome
Intervention: Device: HFV + and - VG
16 Not yet recruiting Thermal Imaging in Neonates: A Feasibility Study in Healthy Babies and Babies With Suspected TTN
Condition: Thermal Imaging, Neonatal Pneumonia, Tachypnea
Intervention: Device: Thermal Imaging
17 Recruiting Glucose Tolerance in Children With Cystic Fibrosis
Conditions: Glucose Intolerance;   Cystic Fibrosis
Intervention: Other: Diagnostics for glucose tolerance with 3 different methods.
18 Not yet recruiting Safety, Pharmacokinetics and Pharmacodynamics Study of Inhaled QBW276 in Patients With Cystic Fibrosis
Condition: Pulmonary Cystic Fibrosis
Interventions: Drug: QBW276;   Other: Placebo
19 Recruiting A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation
Condition: Cystic Fibrosis
Interventions: Drug: VX-661/ivacaftor;   Drug: ivacaftor
20 Recruiting Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation
Condition: Cystic Fibrosis
Intervention: Drug: QR-010

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years